发明公开
EP1673346A1 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF HERPESVIRAL INFECTIONS
审中-公开
用于治疗疱疹病毒感染喹唑啉衍生物
- 专利标题： QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF HERPESVIRAL INFECTIONS
- 专利标题（中）： 用于治疗疱疹病毒感染喹唑啉衍生物
-
申请号： EP04790130.1申请日： 2004-10-05
-
公开(公告)号： EP1673346A1公开(公告)日： 2006-06-28
- 发明人: HERGET, Thomas
- 申请人： GPC Biotech AG
- 申请人地址： Fraunhoferstrasse 20 82152 Martinsried DE
- 专利权人： GPC Biotech AG
- 当前专利权人： GPC Biotech AG
- 当前专利权人地址： Fraunhoferstrasse 20 82152 Martinsried DE
- 代理机构： Maggs, Michael Norman
- 优先权： EP03022647 20031006
- 国际公布： WO2005040125 20050506
- 主分类号： C07D215/44
- IPC分类号： C07D215/44 ; A61K31/517
摘要：
The present invention relates to phenyl-quinazolinyl-amine derivatives and pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising at least one of these derivatives and/or pharmaceutically salts thereof, as well as the use of these derivatives for the prophylaxis and/or treatment of herpesviral induced infections, including opportunistic infections, especially for the prophylaxis and/or treatment of infections and diseases induced by HCMV.
信息查询
